These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18217197)

  • 21. Intravenous immunoglobulin therapy in juvenile dermatomyositis.
    Tsai MJ; Lai CC; Lin SC; Chiang BL; Chou CC; Hsieh KH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(2):111-5. PubMed ID: 9151463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of intravenous Ig therapy in juvenile dermatomyositis.
    Lam CG; Manlhiot C; Pullenayegum EM; Feldman BM
    Ann Rheum Dis; 2011 Dec; 70(12):2089-94. PubMed ID: 21978999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse events.
    Seidling V; Hoffmann JH; Enk AH; Hadaschik EN
    Acta Derm Venereol; 2013 May; 93(3):346-9. PubMed ID: 23073990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study").
    Aggarwal R; Charles-Schoeman C; Schessl J; Dimachkie MM; Beckmann I; Levine T
    Medicine (Baltimore); 2021 Jan; 100(1):e23677. PubMed ID: 33429735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
    Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
    Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis.
    Danieli MG; Calcabrini L; Calabrese V; Marchetti A; Logullo F; Gabrielli A
    Autoimmun Rev; 2009 Dec; 9(2):124-7. PubMed ID: 19386287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Polymyositis: disease course and therapy with intravenously administered immunoglobulins].
    Stoll T; Michel BA; Neidhart M; Wassmer P; Neidl K; Fehr K; Wagenhäuser FJ
    Schweiz Med Wochenschr; 1992 Sep; 122(39):1458-65. PubMed ID: 1411405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current therapy for polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy of intravenously administered immunoglobulin in a case of polymyositis with limited application of steroid therapy.
    Nakamura H; Fujikawa K; Kawakami A; Tamai M; Yamasaki S; Ida H; Eguchi K
    Mod Rheumatol; 2010 Oct; 20(5):496-9. PubMed ID: 20383652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis.
    Danieli MG; Malcangi G; Palmieri C; Logullo F; Salvi A; Piani M; Danieli G
    Ann Rheum Dis; 2002 Jan; 61(1):37-41. PubMed ID: 11779756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
    Bascić-Kes V; Kes P; Zavoreo I; Lisak M; Zadro L; Corić L; Demarin V;
    Acta Clin Croat; 2012 Dec; 51(4):673-83. PubMed ID: 23540178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy of intravenous immunoglobulins for the treatment of dermatomyositis skin lesions without muscle disease.
    Bounfour T; Bouaziz JD; Bézier M; Cordoliani F; Saussine A; Petit A; Juillard C; Bagot M; Rybojad M
    J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1150-7. PubMed ID: 23906502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg.
    Ravaglia S; Piccolo G; Ceroni M; Franciotta D; Pichiecchio A; Bastianello S; Tavazzi E; Minoli L; Marchioni E
    J Neurol; 2007 Nov; 254(11):1518-23. PubMed ID: 17965959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of steroid-resistant polymyositis who made a good response to high dose intravenous immunoglobulins (IVIG)].
    Saito M; Saito Y; Endo K; Tanaka M
    Rinsho Shinkeigaku; 2000 Feb; 40(2):181-3. PubMed ID: 10835943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term, high-dose intravenous immunoglobulin therapy in a patient with banker-type juvenile dermatomyositis.
    Imataka G; Arisaka O
    Cell Biochem Biophys; 2014 Jul; 69(3):747-8. PubMed ID: 24500836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.
    Basta M; Dalakas MC
    J Clin Invest; 1994 Nov; 94(5):1729-35. PubMed ID: 7962520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
    Cherin P
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of intravenous immunoglobulin treatment in refractory uveitis.
    Onal S; Foster CS; Ahmed AR
    Ocul Immunol Inflamm; 2006 Dec; 14(6):367-74. PubMed ID: 17162608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trial of Intravenous Immune Globulin in Dermatomyositis.
    Aggarwal R; Charles-Schoeman C; Schessl J; Bata-Csörgő Z; Dimachkie MM; Griger Z; Moiseev S; Oddis C; Schiopu E; Vencovský J; Beckmann I; Clodi E; Bugrova O; Dankó K; Ernste F; Goyal NA; Heuer M; Hudson M; Hussain YM; Karam C; Magnolo N; Nelson R; Pozur N; Prystupa L; Sárdy M; Valenzuela G; van der Kooi AJ; Vu T; Worm M; Levine T;
    N Engl J Med; 2022 Oct; 387(14):1264-1278. PubMed ID: 36198179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intravenous immunoglobulin treatment in autoimmune diseases].
    Danieli MG; Calcabrini L; Marchetti A; Calabrese V; Pettinari L; Massaccesi C; Gabrielli A; Danieli G
    Recenti Prog Med; 2007 Jun; 98(6):322-6. PubMed ID: 17580523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.